Does perioperative prostaglandin E1 affect survival of patients with esophageal cancer?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

230

HTML

2271

Figures (1-1)

405

Tables (1-3)

212

Sum=3118

Dec 27, 2012 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Surg. Dec 27, 2012; 4(12): 284-288
Published online Dec 27, 2012. doi: 10.4240/wjgs.v4.i12.284

Table 3 Outcome and survival variables

	PGE1 group (n = 15)	Control group (n = 15)	P value
Number of readmissions to hospital¹	2.1 ± 1	1.9 ± 1	0.61
Total duration of readmission (d)¹	27 ± 12	29 ± 12	0.67
The survival rate (mo)¹	10.1 ± 3.8	9.6 ± 3.4	0.71
The overall survival rate after 1 yr	8 (53.3)	7 (47)	0.72
The overall survival rate after 2 yr	3 (20)	3 (20)	0.99
The overall survival rate after 3 yr	0	1 (6.7)	0.99

¹mean ± SD, Student’s t-test; ²Frequency (percent), χ² test or Fisher’s exact test. PGE1: Prostaglandin E1.

Citation: Farrokhnia F, Makarem J, Mahmoodzadeh H, Andalib N. Does perioperative prostaglandin E1 affect survival of patients with esophageal cancer? World J Gastrointest Surg 2012; 4(12): 284-288
URL: https://www.wjgnet.com/1948-9366/full/v4/i12/284.htm
DOI: https://dx.doi.org/10.4240/wjgs.v4.i12.284